Vasomotor symptoms and lipid profiles in women transitioning through menopause

Obstetrics and Gynecology

Volumn 119, Issue 4, 2012, Pages 753-761

  Thurston, Rebecca C ^a,b,c,d,e,f   El Khoudary, Samar R ^a,b,c,d,e,f   Sutton Tyrrell, Kim ^a,b,c,d,e,f   Crandall, Carolyn J ^a,b,c,d,e,f   Gold, Ellen B ^a,b,c,d,e,f   Sternfeld, Barbara ^a,b,c,d,e,f   Joffe, Hadine ^a,b,c,d,e,f   Selzer, Faith ^a,b,c,d,e,f   Matthews, Karen A ^a,b,c,d,e,f  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e DIVISION OF RESEARCH   (United States)

^f MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; ESTRADIOL; FOLLITROPIN; HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; CARDIOVASCULAR RISK; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HOT FLUSH; HUMAN; LEAN BODY WEIGHT; LIPID ANALYSIS; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MENOPAUSE; NIGHT SWEAT; PRIORITY JOURNAL; SYMPTOM; TRIACYLGLYCEROL BLOOD LEVEL; VASOMOTOR DISORDER;

ADULT; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HOT FLASHES; HUMANS; LIPOPROTEINS; MENOPAUSE; MIDDLE AGED; SWEATING; TRIGLYCERIDES; VASOMOTOR SYSTEM;

EID: 84859065346     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1097/AOG.0b013e31824a09ec     Document Type: Article

References (33)

1. Gold E, Colvin A, Avis N, Bromberger J, Greendale G, Powell L, et al. Longitudinal analysis of vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women's Health Across the Nation (SWAN). Am J Public Health 2006;96:1226-35. (Pubitemid 43967848)
2. Szmuilowicz ED, Manson JE, Rossouw JE, Howard BV, Margolis KL, Greep NC, et al. Vasomotor symptoms and cardiovascular events in postmenopausal women. Menopause 2011;18:603-10.
3. Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465-77. (Pubitemid 46556472)
4. Huang AJ, Sawaya GF, Vittinghoff E, Lin F, Grady D. Hot flushes, coronary heart disease, and hormone therapy in postmenopausal women. Menopause 2009;16:639-43.
5. Thurston RC, Sutton-Tyrrell K, Everson-Rose SA, Hess R, Matthews KA. Hot flashes and subclinical cardiovascular disease: findings from the Study of Women's Health Across the Nation Heart Study. Circulation 2008;118:1234-40.
6. Bechlioulis A, Kalantaridou SN, Naka KK, Chatzikyriakidou A, Calis KA, Makrigiannakis A, et al. Endothelial function, but not carotid intima-media thickness, is affected early in menopause and is associated with severity of hot flushes. J Clin Endocrinol Metab 2010;95:1199-206.
7. Thurston RC, Sutton-Tyrrell K, Everson-Rose S, Hess R, Powell L, Matthews K. Hot flashes and carotid intima media thickness among midlife women. Menopause 2011;18:352-8.
8. Gast GC, Grobbee DE, Pop VJ, Keyzer JJ, Wijnands-van Gent CJ, Samsioe GN, et al. Menopausal complaints are associated with cardiovascular risk factors. Hypertension 2008;51:1492-8.
9. Gast GC, Samsioe GN, Grobbee DE, Nilsson PM, van der Schouw YT. Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women. Maturitas 2010;66:285-90.
10. Tuomikoski P, Mikkola TS, Hamalainen E, Tikkanen MJ, Turpeinen U, Ylikorkala O. Biochemical markers for cardiovascular disease in recently postmenopausal women with or without hot flashes. Menopause 2010;17:145-51.
11. Sassarini J, Fox H, Ferrell W, Sattar N, Lumsden MA. Vascular function and cardiovascular risk factors in women with severe flushing. Clin Endocrinol (Oxf) 2011;74:97-103.
12. Sowers M, Crawford S, Sternfeld B, Morganstein D, Gold EB, Greendale GA, et al. SWAN: a multicenter, multiethnic, community-based cohort study of women and the menopausal transition. In: Lobo RA, Kelsey J, Marcus R, Lobo AR, editors. Menopause: biology and pathology. New York (NY): Academic Press; 2000. p. 175-88.
13. Steiner P, Friedel J, Bremner W, Stein E. Standardization of micro-methods for plasma cholesterol, triglyceride and HDL-cholesterol with the Lipid Research Clinics' methodology. J Clin Chem Clin Biochem 1981;19:850.
14. Warnick G, Albers J. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 1978;19:65-76. (Pubitemid 8268303)
15. Friedewald W, Levy R, Fredrickson D. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
16. Myers G, Cooper G, Winn C, Smith S. The Centers for Disease Control-National Heart, Lung and Blood Institute Lipid Standardization Program: an approach to accurate and precise lipid measurements. Clin Lab Med 1989;9:105-35. (Pubitemid 19070302)
17. England BG, Parsons GH, Possley RM, McConnell DS, Midgley AR. Ultrasensitive semiautomated chemiluminescent immunoassay for estradiol. Clin Chem 2002;48:1584-6. (Pubitemid 34925797)
18. Ainsworth BE, Sternfeld B, Richardson MT, Jackson K. Evaluation of the kaiser physical activity survey in women. Med Sci Sports Exerc 2000;32:1327-38. (Pubitemid 30482665)
19. Thurston R, El Khoudary S, Sutton-Tyrrell K, Crandall C, Gold E, Sternfeld B, et al. Are vasomotor symptoms associated with alterations in hemostatic and inflammatory markers? Findings from the Study of Women's Health Across the Nation. Menopause 2011;18:1044-51.
20. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1977;1:385-401.
21. Kubzansky LD, Kawachi I, Weiss ST, Sparrow D. Anxiety and coronary heart disease: a synthesis of epidemiological, psychological, and experimental evidence. Ann Behav Med 1998;20:47-58. (Pubitemid 29071466)
22. Lett HS, Blumenthal JA, Babyak MA, Sherwood A, Strauman T, Robins C, et al. Depression as a risk factor for coronary artery disease: evidence, mechanisms, and treatment. Psychosom Med 2004;66:305-15. (Pubitemid 38668397)
23. Fitzmaurice G, Laird N, Ware J Applied longitudinal analysis. Hoboken (NJ): Wiley-Interscience; 2004.
24. Akaike H. A new look at the statistical model identification. IEEE Trans on Automat Contr 1974;19:716-23.
25. Derby CA, Crawford SL, Pasternak RC, Sowers M, Sternfeld B, Matthews KA. Lipid changes during the menopause transition in relation to age and weight: the Study of Women's Health Across the Nation. Am J Epidemiol 2009;169:1352-61.
26. Woodward M. Epidemiology: study design and data analysis New York (NY): Chapman and Hall/CRC; 1999.
27. Matthews KA, Crawford SL, Chae CU, Everson-Rose SA, Sowers MF, Sternfeld B, et al. Are changes in cardiovascular disease risk factors in midlife women due to chronological aging or to the menopausal transition? J Am Coll Cardiol 2009;54:2366-73.
28. Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, et al. Effectiveness-based guidelines for the prevention of cardiovascular disease in women-2011 update: a guideline from the American Heart Association. Circulation 2011;123:1243-62.
29. Woodard GA, Brooks MM, Barinas-Mitchell E, Mackey RH, Matthews KA, Sutton-Tyrrell K. Lipids, menopause, and early atherosclerosis in Study of Women's Health Across the Nation Heart women. Menopause 2011;18:376-84.
30. Fan A, Dwyer J. Sex differences in the relation of HDL cholesterol to progression of carotid intima-media thickness: the Los Angeles Atherosclerosis Study. Atherosclerosis 2007;195:e191-6. (Pubitemid 47561968)
31. Asztalos BF, Collins D, Cupples LA, Demissie S, Horvath KV, Bloomfield HE, et al. Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol 2005;25:2185-91. (Pubitemid 41416319)
32. Thurston R, Christie I, Matthews K. Hot flashes and cardiac vagal control: A link to cardiovascular risk? Menopause 2010;17:456-61.
33. Woods NF, Mitchell ES, Smith-Dijulio K. Cortisol levels during the menopausal transition and early postmenopause: observations from the Seattle Midlife Women's Health Study. Menopause 2009;16:708-18.